AXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti …
CannabinoidsNEW YORK, April 18, 2018 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent Office (EPO) has published a patent application owned by the Company for an invention entitled “Anti-Microbial Composition Comprising Cannabinoids,” EU Patent Publication Number 16815133.0. The patent application, […]